Moreover, elevated expression of PD-L1 and/or altered expression of PD-L1-targeted miRNAs in exosomes derived from tumor cells were also observed in several studies [233–235], suggesting that they may act as either potential therapeutic targets or biomarkers in ICTs [236, 237]. Here, CD274 is linked to neoplasm.